cmAngio® vs Eko Low Ejection Fraction Tool (ELEFT)
AI Verdict
Choose cmAngio® if…
Choose cmAngio® if your facility aims to enhance women's cardiovascular risk assessment by leveraging existing mammography exams. This AI software identifies Breast Arterial Calcifications (BAC) on both FFDM and DBT, providing valuable insights into cardiovascular health without additional procedures. It's ideal for integrating opportunistic cardiovascular screening into routine breast imaging workflows.
View cmAngio® →Choose Eko Low Ejection Fraction Tool (ELEFT) if…
Choose Eko Low Ejection Fraction Tool (ELEFT) if your clinicians need a rapid, non-invasive screening solution for low ejection fraction during routine physical examinations. This AI algorithm integrates with Eko digital stethoscopes to provide quick results, making it highly suitable for early heart failure risk identification at the point of care in primary care or cardiology settings.
View Eko Low Ejection Fraction Tool (ELEFT) →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | cmAngio® | Eko Low Ejection Fraction Tool (ELEFT) |
|---|---|---|
| Pricing | Paid, out-of-pocket | Unknown |
| Deployment | Cloud-based, integrates with any DICOM-compliant viewer | Unknown |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
cmAngio®Tool A emphasizes ease of integration with existing radiology workflows, being compatible with any DICOM-compliant viewer and offering quick installation in less than an hour. While Tool B provides rapid results, it requires integration with specific Eko digital stethoscopes, potentially limiting its universal applicability in diverse clinical settings.
Clinical Value
TieBoth tools offer significant clinical value by addressing critical cardiovascular health needs with FDA-cleared AI. Tool A leverages existing mammogram data to assess cardiovascular risk without additional procedures, while Tool B provides real-time, non-invasive detection of heart failure indicators during routine physical exams. Both enhance early risk assessment and patient care.
Pricing & Value
cmAngio®Both tools require direct contact for pricing details, indicating a lack of public transparency. However, Tool A explicitly mentions 'Limited-time offers for no-cost implementation and service may be available,' which could offer a significant initial value proposition. Tool B is noted as part of an 'enterprise solution,' which might imply a higher or more complex bundled cost.
Enterprise Readiness
Eko Low Ejection Fraction Tool (ELEFT)Both tools are FDA-cleared, HIPAA-compliant, and cloud-based, demonstrating foundational enterprise readiness. However, Tool B explicitly confirms having a Business Associate Agreement (BAA) in the structured facts and is positioned as part of an 'enterprise solution,' indicating a more explicit focus on large-scale deployment and comprehensive compliance.
Innovation
cmAngio®While both are innovative AI tools, Tool A stands out by repurposing existing mammography data to detect Breast Arterial Calcifications (BAC) for cardiovascular risk assessment, adding significant value without requiring new patient procedures or radiation. This novel application of AI to an established screening method is a particularly efficient and impactful innovation.
Support & Docs
Eko Low Ejection Fraction Tool (ELEFT)Based on web search, Eko Health (Tool B) provides a comprehensive online help center, including user manuals for the ELEFT, and various contact options for support. CureMetrix (Tool A) offers general contact information for support but less specific documentation publicly available for cmAngio.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | cmAngio® | Eko Low Ejection Fraction Tool (ELEFT) |
|---|---|---|
| Tool Name | cmAngiou00ae | Eko Low Ejection Fraction Tool (ELEFT) |
| Company | CureMetrix | Eko Health |
| Primary Function | AI software for detecting Breast Arterial Calcifications (BAC) on mammograms. | AI algorithm to aid in early detection of low ejection fraction during routine physical exams. |
| Key Data Input | Full-Field Digital Mammography (FFDM) and Digital Breast Tomosynthesis (DBT) exams | ECG and heart sound recordings from Eko digital stethoscopes |
| Specialties | Cardiology, Obstetrics & Gynecology, Radiology | Cardiology, Family Medicine, Internal Medicine |
Videos
Demos, reviews, and walkthroughs featuring cmAngio® and Eko Low Ejection Fraction Tool (ELEFT).
Frequently Asked Questions
More Comparisons
More matchups featuring cmAngio® or Eko Low Ejection Fraction Tool (ELEFT)
Backers
Who funded each tool's parent company.